⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for recombinant immunotoxin

Every month we try and update this database with for recombinant immunotoxin cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
SS1(dsFV)PE38 Plus Pemetrexed and Cisplatin to Treat Malignant Pleural MesotheliomaNCT01445392
Mesothelioma
Multicycle SS1P
Pemetrexed
Cisplatin
Single cycle SS...
18 Years - 100 YearsNational Institutes of Health Clinical Center (CC)
Moxetumomab Pasudotox-tdfk (Lumoxiti(TM)) and Either Rituximab (Rituxan(R)) or Ruxience for Relapsed Hairy Cell LeukemiaNCT03805932
Hairy Cell Leuk...
Moxetumomab Pas...
Rituximab
Ruxience
Dexamethasone
Acetaminophen
Diphenhydramine
Famotidine
Aspirin
18 Years - National Institutes of Health Clinical Center (CC)
SS1(dsFV)PE38 Plus Pemetrexed and Cisplatin to Treat Malignant Pleural MesotheliomaNCT01445392
Mesothelioma
Multicycle SS1P
Pemetrexed
Cisplatin
Single cycle SS...
18 Years - 100 YearsNational Institutes of Health Clinical Center (CC)
Phase II Study of the Efficacy and Toxicity of Ontak(Registered Trademark) (Denileukin Diftitox) in the Therapy of Adult T-Cell LeukemiaNCT00117845
Leukemia, Adult...
Denileukin dift...
18 Years - National Institutes of Health Clinical Center (CC)
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: